Europe needs to refocus biotech policies
This article was originally published in Clinica
Europe needs to invest more and unify its biotech policies to raise its competitiveness and profile worldwide. This is the thrust of a strategy document presented on January 24 by the European Commission. The text proposes ways in which Europe can best profit from the opportunities in biotechnology and life sciences and will be examined at the European Council meeting in Barcelona in March.